# ALBANY MOLECULAR RESEARCH INC

ALBANY MOLECULAR RESEARCH INC is a company headquartered in Albany, NY, United States.

## Company overview

- **Legal name:** ALBANY MOLECULAR RESEARCH INC
- **Classification:** Company
- **Industry (SIC):** 8731 — Services-Commercial Physical & Biological Research
- **Headquarters:** Albany, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001065087

## About

ALBANY MOLECULAR RESEARCH INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001065087, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2017-03-16, it reported annual revenue of USD 570,450,000; net income of USD -70,171,000; total assets of USD 1,209,648,000 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $570.5M (USD 570,450,000)
- **Net income:** -$70.2M (USD -70,171,000)
- **Total assets:** $1.2B (USD 1,209,648,000)
- **Cash and equivalents:** $52.0M (USD 52,000,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $402.4M (USD 402,356,000)
- **Net income:** -$2.3M (USD -2,301,000)
- **Total assets:** $865.6M (USD 865,567,000)
- **Cash and equivalents:** $49.3M (USD 49,343,000)
- **Operating cash flow:** $39.6M (USD 39,628,000)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $276.6M (USD 276,571,000)
- **Net income:** -$3.3M (USD -3,278,000)
- **Total assets:** $520.0M (USD 519,953,000)
- **Cash and equivalents:** $47.0M (USD 46,995,000)
- **Operating cash flow:** $1.9M (USD 1,905,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $246.6M (USD 246,575,000)
- **Net income:** $12.7M (USD 12,680,000)
- **Total assets:** $445.3M (USD 445,268,000)
- **Cash and equivalents:** $175.9M (USD 175,928,000)
- **Operating cash flow:** $28.2M (USD 28,176,000)
- **Later filings:** Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2017-08-31 — period 2017-08-31 — FORM 8-K
- Form 8-K — filed 2017-08-18 — period 2017-08-18 — FORM 8-K
- Form 10-Q — filed 2017-08-09 — period 2017-06-30 — FORM 10-Q
- Form 8-K — filed 2017-07-10 — period 2017-07-10 — 8-K
- Form 8-K — filed 2017-06-29 — period 2017-06-26 — FORM 8-K
- Form 8-K — filed 2017-06-06 — period 2017-06-05 — 8-K
- Form 8-K — filed 2017-06-01 — period 2017-05-31 — FORM 8-K
- Form 10-Q — filed 2017-05-10 — period 2017-03-31 — FORM 10-Q
- Form 10-K/A — filed 2017-05-10 — period 2016-12-31 — FORM 10-K/A
- Form 8-K — filed 2017-05-10 — period 2017-05-09 — FORM 8-K
- Form DEF 14A — filed 2017-04-19 — period 2017-05-31 — DEF 14A
- Form 10-K — filed 2017-03-16 — period 2016-12-31 — 10-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/albany-molecular-research-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology